Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

826 to 850 of 925 results

Government, academic and venture firms come together in March to fund translational and early-stage development

02-04-2012

A host of new initiatives focused on funding translational research and early-stage companies brought…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Valeant to buy Russian OTC drugmaker

27-03-2012

In its third takeover announcement this year, Canadian drugmaker Valeant Pharmaceuticals International…

Mergers & AcquisitionsNatur ProduktPharmaceuticalValeant Pharmaceuticals

Islet Sciences closes stock acquisition of diabetes drug developer DiaKine

26-03-2012

New York. USA-based biotech company Islet Sciences (OTC.BB: ISLT),said Friday that it has closed its…

BiotechnologyDiabetesDiaKine TherapeuticsIslet SciencesMergers & Acquisitions

Anaphore buys Chinese firm RuiYi for GPCR biologics platform

23-03-2012

Privately-held US company Anaphore says it has acquired Shanghai, China-based RuiYi, bringing the company…

AnaphoreAsia-PacificBiotechnologyMergers & AcquisitionsRuiYi

NicOx takes option to buy UK ophthalmic company

22-03-2012

French biotechnology firm NicOx (Euronext Paris: COX) has entered into an agreement to acquire 11.8%…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

AbbVie selected as name for Abbott research-based spin out

22-03-2012

Confirming its previous announcements on plans to split the US health care major, Abbott Laboratories…

Abbott LaboratoriesAbbVieMergers & AcquisitionsPharmaceutical

Synergy Health buys only Swiss gamma and X-ray irradiation facility

19-03-2012

UK-based Synergy Health (LSE: SYR), a provider of outsourced sterilization services to the medical device…

Leoni StuderMergers & AcquisitionsPharmaceuticalSynergy Health

Flamel Tech acquires US firm Eclat Pharma; reports loss

19-03-2012

Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Grifols acquires 51% stake in Araclon Biotech

19-03-2012

Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Sanofi expands in biosurgery, buying Pluromed

18-03-2012

French drug major Sanofi (Euronext: SAN) said on Friday that it is to acquire Pluromed, a USA-based medical…

Mergers & AcquisitionsPharmaceuticalPluromedSanofi

Shire to acquire FerroKin BioSciences; drops Replagal BLA

16-03-2012

Ireland-headquartered Shire (LSE: SHP) said yesterday that it has signed an agreement to acquire privately-held…

FerroKin BioSciencesMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalRare diseasesRegulationReplagalShire

GlaxoSmithKline off loads more OTC brands

15-03-2012

Following its earlier announcement that it intends to divest non-core Consumer Healthcare over-the-counter…

GlaxoSmithKlineMergers & AcquisitionsOmega PharmaPharmaceutical

Valeant goes shopping again, buying branded generics from Gerot Lannach

14-03-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

AspirinGenericsGerot LannachMergers & AcquisitionsValeant Pharmaceuticals

Prestige Brands rejects hostile bid from Mexican drugmaker

14-03-2012

US OTC and household products company Prestige Brands Holdings (NYSE: PBH) has turned down an $834 million…

Genomma LabMergers & AcquisitionsPharmaceuticalPrestige Brands

Valeant on acquisition trail again

12-03-2012

In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International…

BiotechnologyMergers & AcquisitionsPele Nova BiotecnologiaPharmaceuticalRegedermSouth AmericaValeant Pharmaceuticals

Roche has options beyond Illumina

07-03-2012

Speaking at the companys annual meeting, Swiss drug maj'or Roche (ROG: SIX) chairman Franz Humer said:…

FinancialIlluminaMergers & AcquisitionsPharmaceuticalRoche

Abcam to buy Epitomics for $170 million

06-03-2012

In a second acquisition within six months, UK-based protein research tools supplier Abcam (AIM: ABC)…

AbcamEpitomics InternationalFinancialMergers & AcquisitionsPharmaceutical

Amgen says tender offer for Micromet on track

04-03-2012

Global biotech leader Amgen (Nasdaq: AMGN) says that all conditions to the closing of the tender offer…

AmgenBiotechnologyMergers & AcquisitionsMicromet

826 to 850 of 925 results

Parexel

Parexel

Back to top